Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dopamine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers

  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Verdejo-Garcia, Antonio|||0000-0001-8874-9339
  • Granero, Roser|||0000-0001-6308-3198
  • Penelo Werner, Eva|||0000-0001-6796-7660
  • Gené Badia, Manel
  • Barrot, Carme|||0000-0002-3141-4092
  • Sánchez, Cristina
  • Alvarez Moya, Eva Maria|||0000-0002-3723-3225
  • Ochoa, Cristian|||0000-0002-4508-0951
  • Aymamí, Neus|||0000-0002-4607-9565
  • Gomez-Peña, Monica|||0000-0001-6194-8266
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
Like drug addiction, pathological gambling (PG) has been associated with impairments in executive functions and alterations in dopaminergic functioning; however, the role of dopamine (DA) in the executive profile of PG remains unclear. The aim of this study was to identify whether the DRD2/ANKK1 Taq1Ars1800497 and the DAT1-40 bp VNTR polymorphisms are associated with cognitive flexibility (measured by Wisconsin Card Sorting Test (WCST) and Trail Making Test (TMT)) and inhibition response (measured by Stroop Color and Word Test (SCWT)), in a clinical sample of 69 PG patients. Our results showed an association between DA functioning and cognitive flexibility performance. The Taq1A A1+ (A1A2/A1A1) genotype was associated with poorer TMT performance (p < 0.05), while DAT1 9-repeat homozygotes displayed better WCST performance (p < 0.05) than either 10-repeat homozygotes or heterozygotes. We did not find any association between the DRD2 or DAT1 polymorphisms and the inhibition response. These results suggested that pathological gamblers with genetic predispositions toward lower availability of DA and D2 receptor density are at a higher risk of cognitive flexibility difficulties. Future studies should aim to shed more light on the genetic mechanisms underlying the executive profile in PG.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity

  • Fagundo, Ana B.
  • Torre Fornell, Rafael de la
  • Jiménez Murcia, Susana
  • Agüera, Zaida
  • Granero, Roser
  • Tárrega, Salomé
  • Botella, Cristina
  • Baños, Rosa M.
  • Fernández Real, Jose M.
  • Rodríguez, Roser
  • Forcano, Laura
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Tinahones Madueño, Francisco José
  • Fernández García, José C.
  • Casanueva, Felipe F.
  • Fernández Aranda, Fernando
Background: Extreme weight conditions (EWC) groups along a continuum may share some biological risk factors and intermediate neurocognitive phenotypes. A core cognitive trait in EWC appears to be executive dysfunction, with a focus on decision making, response inhibition and cognitive flexibility. Differences between individuals in these areas are likely to contribute to the differences in vulnerability to EWC. The aim of the study was to investigate whether there is a common pattern of executive dysfunction in EWC while comparing anorexia nervosa patients (AN), obese subjects (OB) and healthy eating/weight controls (HC). Methods: Thirty five AN patients, fifty two OB and one hundred thirty seven HC were compared using the Wisconsin Card Sorting Test (WCST); Stroop Color and Word Test (SCWT); and Iowa Gambling Task (IGT). All participants were female, aged between 18 and 60 years. Results: There was a significant difference in IGT score (F(1.79); p<.001), with AN and OB groups showing the poorest performance compared to HC. On the WCST, AN and OB made significantly more errors than controls (F(25.73); p<.001), and had significantly fewer correct responses (F(2.71); p<.001). Post hoc analysis revealed that the two clinical groups were not significantly different from each other. Finally, OB showed a significant reduced performance in the inhibition response measured with the Stroop test (F(5.11); p<.001) compared with both AN and HC. Conclusions: These findings suggest that EWC subjects (namely AN and OB) have similar dysfunctional executive profile that may play a role in the development and maintenance of such disorders, Financial support was received from Fondo de Investigación Sanitaria -FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718); Ministerio de Ciencia e Innovación Subprograma Juan de la Cierva (JCI-2011-09248); CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCIII
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Modulation of the endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on executive functions in humans

  • Fagundo, Ana B.
  • Torre Fornell, Rafael de la
  • Jiménez Murcia, Susana
  • Agüera, Zaida
  • Pastor, Antonio
  • Casanueva, Felipe F.
  • Granero, Roser
  • Baños, Rosa M.
  • Botella, Cristina
  • de Pino Gutiárrez, Amparo
  • Fernández Real, Jose M.
  • Fernández García, José C.
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Menchón, José M.
  • Moragrega, Inés
  • Rodríguez, Roser
  • Tárrega, Salomé
  • Tinahones Madueño, Francisco José
  • Fernández Aranda, Fernando
Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognitive flexibility) in healthy subjects. One hundred and fifty seven subjects were included and assessed with the Wisconsin Card Sorting Test; Stroop Color and Word Test; and Iowa Gambling Task. All participants were female, aged between 18 and 60 years and spoke Spanish as their first language. Results showed a negative correlation between 2-AG and cognitive flexibility performance (r = −.37; p<.05). A positive correlation was found between AEA concentrations and both cognitive flexibility (r = .59; p<.05) and decision making performance (r = .23; P<.05). There was no significant correlation between either 2-AG (r = −.17) or AEA (r = −.08) concentrations and inhibition response. These results show, in humans, a relevant modulation of the endocannabinoid system on prefrontal-dependent cognitive functioning. The present study might have significant implications for the underlying executive alterations described in some psychiatric disorders currently associated with endocannabinoids deregulation (namely drug abuse/dependence, depression, obesity and eating disorders). Understanding the neurobiology of their dysexecutive profile might certainly contribute to the development of new treatments and pharmacological approaches., Financial support was received from Fondo de Investigación Sanitaria - FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718). Ministerio de Ciencia e Innovación Subprograma Juan de la Cierva (JCI-2011-09248). CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCII
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Modulation of Higher-Order Olfaction Components on Executive Functions in Humans.

  • Fagundo, Ana B.
  • Jiménez Murcia, Susana
  • Giner Bartolomé, Cristina
  • Anisul Islam, Mohammed
  • Torre Fornell, Rafael de la
  • Pastor, Antonio
  • Casanueva, Felipe F.
  • Crujeiras, Ana B.
  • Granero, Roser
  • Baños, Rosa M.
  • Botella, Cristina
  • Fernández Real, Jose M.
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Menchón, José M.
  • Tinahones Madueño, Francisco José
  • Fernández Aranda, Fernando
The prefrontal (PFC) and orbitofrontal cortex (OFC) appear to be associated with both executive functions and olfaction. However, there is little data relating olfactory processing and executive functions in humans. The present study aimed at exploring the role of olfaction on executive functioning, making a distinction between primary and more cognitive aspects of olfaction. Three executive tasks of similar difficulty were used. One was used to assess hot executive functions (Iowa Gambling Task-IGT), and two as a measure of cold executive functioning (Stroop Colour and Word Test-SCWT and Wisconsin Card Sorting Test-WCST). Sixty two healthy participants were included: 31 with normosmia and 31 with hyposmia. Olfactory abilities were assessed using the ''Sniffin' Sticks'' test and the olfactory threshold, odour discrimination and odour identification measures were obtained. All participants were female, aged between 18 and 60. Results showed that participants with hyposmia displayed worse performance in decision making (IGT; Cohen's-d = 0.91) and cognitive flexibility (WCST; Cohen's-d between 0.54 and 0.68) compared to those with normosmia. Multiple regression adjusted by the covariates participants' age and education level showed a positive association between odour identification and the cognitive inhibition response (SCWT-interference; Beta = 0.29; p = .034). The odour discrimination capacity was not a predictor of the cognitive executive performance. Our results suggest that both hot and cold executive functions seem to be associated with higher-order olfactory functioning in humans. These results robustly support the hypothesis that olfaction and executive measures have a common neural substrate in PFC and OFC, and suggest that olfaction might be a reliable cognitive marker in psychiatric and neurologic disorders., This work was supported by the Fondo de Investigación Sanitaria (FIS, Foundation for Health Investigation, grant number PI11/210), Ministerio de Economía y Competitividad (The Spanish Ministry of Economy and Competitiveness, grant number PSI2011-28349) and Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, grant numbers 2014SGR1672 and 2014SGR680). ABF was supported by the Ministerio de Ciencia e Innovación Subprograma Juan de la Cierva (Ministry of Science and Innovation, Juan de la Cierva Subprogram, grant number JCI-2011-09248). In addition, the Centros de Investigación Biomédica en Red (CIBER) programs are supported by Instituto de Salud Carlos III (ISCIII).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index

  • Pardo, María Luisa
  • Crujeiras, Ana B.
  • Amil, María
  • Agüera, Zaida
  • Jiménez Murcia, Susana
  • Baños, Rosa M.
  • Botella, Cristina
  • Torre Fornell, Rafael de la
  • Estivill, Xavier, 1955-
  • Fagundo, Ana B.
  • Fernández Real, Jose M.
  • Fernández García, José C.
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Rodríguez, Roser
  • Tinahones Madueño, Francisco José
  • Fernández Aranda, Fernando
  • Casanueva, Felipe F.
FNDC5/irisin has been recently postulated as beneficial in the treatment of obesity and diabetes because it is induced in muscle by exercise, increasing energy expenditure. However, recent reports have shown that WAT also secretes irisin and that circulating irisin is elevated in obese subjects. The aim of this study was to evaluate irisin levels in conditions of extreme BMI and its correlation with basal metabolism and daily activity. The study involved 145 female patients, including 96 with extreme BMIs (30 anorexic (AN) and 66 obese (OB)) and 49 healthy normal weight (NW). The plasma irisin levels were significantly elevated in the OB patients compared with the AN and NW patients. Irisin also correlated positively with body weight, BMI, and fat mass. The OB patients exhibited the highest REE and higher daily physical activity compared with the AN patients but lower activity compared with the NW patients. The irisin levels were inversely correlated with daily physical activity and directly correlated with REE. Fat mass contributed to most of the variability of the irisin plasma levels independently of the other studied parameters. Conclusion. Irisin levels are influenced by energy expenditure independently of daily physical activity but fat mass is the main contributing factor., This work was supported by CIBERobn (CB06/03), INTRASALUD Project (no. PI10/02464), and PI13/01915, Instituto de Salud Carlos III (ISCIII) initiatives. The study was also supported by Fondo de Investigación Sanitaria-FIS (PI11/210) and AGAUR (2009SGR1554). Ana B. Crujeiras is funded by the ISCIII through a research contract “Sara Borrell” (C09/00365). María Pardo is a Miguel Servet Fellow (ISCIII/SERGAS). Ana B. Fagundo is funded by Ministerio de Ciencia e Innovación Subprograma through a research contract Juan de la Cierva (JCI-2011-09248). José C. Fernández-García is recipient of a “Rio Hortega” contract from “Instituto de Salud Carlos III,” Madrid, Spain (CM12/00059)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index

  • Pardo, María Luisa
  • Crujeiras, Ana B.
  • Amil, María
  • Agüera, Zaida
  • Jiménez Murcia, Susana
  • Baños, Rosa M.
  • Botella, Cristina
  • Torre Fornell, Rafael de la
  • Estivill, Xavier, 1955-
  • Fagundo, Ana B.
  • Fernández Real, Jose M.
  • Fernández García, José C.
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Rodríguez, Roser
  • Tinahones Madueño, Francisco José
  • Fernández Aranda, Fernando
  • Casanueva, Felipe F.
FNDC5/irisin has been recently postulated as beneficial in the treatment of obesity and diabetes because it is induced in muscle by exercise, increasing energy expenditure. However, recent reports have shown that WAT also secretes irisin and that circulating irisin is elevated in obese subjects. The aim of this study was to evaluate irisin levels in conditions of extreme BMI and its correlation with basal metabolism and daily activity. The study involved 145 female patients, including 96 with extreme BMIs (30 anorexic (AN) and 66 obese (OB)) and 49 healthy normal weight (NW). The plasma irisin levels were significantly elevated in the OB patients compared with the AN and NW patients. Irisin also correlated positively with body weight, BMI, and fat mass. The OB patients exhibited the highest REE and higher daily physical activity compared with the AN patients but lower activity compared with the NW patients. The irisin levels were inversely correlated with daily physical activity and directly correlated with REE. Fat mass contributed to most of the variability of the irisin plasma levels independently of the other studied parameters. Conclusion. Irisin levels are influenced by energy expenditure independently of daily physical activity but fat mass is the main contributing factor., This work was supported by CIBERobn (CB06/03), INTRASALUD Project (no. PI10/02464), and PI13/01915, Instituto de Salud Carlos III (ISCIII) initiatives. The study was also supported by Fondo de Investigación Sanitaria-FIS (PI11/210) and AGAUR (2009SGR1554). Ana B. Crujeiras is funded by the ISCIII through a research contract “Sara Borrell” (C09/00365). María Pardo is a Miguel Servet Fellow (ISCIII/SERGAS). Ana B. Fagundo is funded by Ministerio de Ciencia e Innovación Subprograma through a research contract Juan de la Cierva (JCI-2011-09248). José C. Fernández-García is recipient of a “Rio Hortega” contract from “Instituto de Salud Carlos III,” Madrid, Spain (CM12/00059)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity

  • Fagundo, Ana B.
  • Torre Fornell, Rafael de la
  • Jiménez Murcia, Susana
  • Agüera, Zaida
  • Granero, Roser
  • Tárrega, Salomé
  • Botella, Cristina
  • Baños, Rosa M.
  • Fernández Real, Jose M.
  • Rodríguez, Roser
  • Forcano, Laura
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Tinahones Madueño, Francisco José
  • Fernández García, José C.
  • Casanueva, Felipe F.
  • Fernández Aranda, Fernando
Background: Extreme weight conditions (EWC) groups along a continuum may share some biological risk factors and intermediate neurocognitive phenotypes. A core cognitive trait in EWC appears to be executive dysfunction, with a focus on decision making, response inhibition and cognitive flexibility. Differences between individuals in these areas are likely to contribute to the differences in vulnerability to EWC. The aim of the study was to investigate whether there is a common pattern of executive dysfunction in EWC while comparing anorexia nervosa patients (AN), obese subjects (OB) and healthy eating/weight controls (HC). Methods: Thirty five AN patients, fifty two OB and one hundred thirty seven HC were compared using the Wisconsin Card Sorting Test (WCST); Stroop Color and Word Test (SCWT); and Iowa Gambling Task (IGT). All participants were female, aged between 18 and 60 years. Results: There was a significant difference in IGT score (F(1.79); p<.001), with AN and OB groups showing the poorest performance compared to HC. On the WCST, AN and OB made significantly more errors than controls (F(25.73); p<.001), and had significantly fewer correct responses (F(2.71); p<.001). Post hoc analysis revealed that the two clinical groups were not significantly different from each other. Finally, OB showed a significant reduced performance in the inhibition response measured with the Stroop test (F(5.11); p<.001) compared with both AN and HC. Conclusions: These findings suggest that EWC subjects (namely AN and OB) have similar dysfunctional executive profile that may play a role in the development and maintenance of such disorders, Financial support was received from Fondo de Investigación Sanitaria -FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718); Ministerio de Ciencia e Innovación Subprograma Juan de la Cierva (JCI-2011-09248); CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCIII
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Modulation of Higher-Order Olfaction Components on Executive Functions in Humans.

  • Fagundo, Ana B.
  • Jiménez Murcia, Susana
  • Giner Bartolomé, Cristina
  • Anisul Islam, Mohammed
  • Torre Fornell, Rafael de la
  • Pastor, Antonio
  • Casanueva, Felipe F.
  • Crujeiras, Ana B.
  • Granero, Roser
  • Baños, Rosa M.
  • Botella, Cristina
  • Fernández Real, Jose M.
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Menchón, José M.
  • Tinahones Madueño, Francisco José
  • Fernández Aranda, Fernando
The prefrontal (PFC) and orbitofrontal cortex (OFC) appear to be associated with both executive functions and olfaction. However, there is little data relating olfactory processing and executive functions in humans. The present study aimed at exploring the role of olfaction on executive functioning, making a distinction between primary and more cognitive aspects of olfaction. Three executive tasks of similar difficulty were used. One was used to assess hot executive functions (Iowa Gambling Task-IGT), and two as a measure of cold executive functioning (Stroop Colour and Word Test-SCWT and Wisconsin Card Sorting Test-WCST). Sixty two healthy participants were included: 31 with normosmia and 31 with hyposmia. Olfactory abilities were assessed using the ''Sniffin' Sticks'' test and the olfactory threshold, odour discrimination and odour identification measures were obtained. All participants were female, aged between 18 and 60. Results showed that participants with hyposmia displayed worse performance in decision making (IGT; Cohen's-d = 0.91) and cognitive flexibility (WCST; Cohen's-d between 0.54 and 0.68) compared to those with normosmia. Multiple regression adjusted by the covariates participants' age and education level showed a positive association between odour identification and the cognitive inhibition response (SCWT-interference; Beta = 0.29; p = .034). The odour discrimination capacity was not a predictor of the cognitive executive performance. Our results suggest that both hot and cold executive functions seem to be associated with higher-order olfactory functioning in humans. These results robustly support the hypothesis that olfaction and executive measures have a common neural substrate in PFC and OFC, and suggest that olfaction might be a reliable cognitive marker in psychiatric and neurologic disorders., This work was supported by the Fondo de Investigación Sanitaria (FIS, Foundation for Health Investigation, grant number PI11/210), Ministerio de Economía y Competitividad (The Spanish Ministry of Economy and Competitiveness, grant number PSI2011-28349) and Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, grant numbers 2014SGR1672 and 2014SGR680). ABF was supported by the Ministerio de Ciencia e Innovación Subprograma Juan de la Cierva (Ministry of Science and Innovation, Juan de la Cierva Subprogram, grant number JCI-2011-09248). In addition, the Centros de Investigación Biomédica en Red (CIBER) programs are supported by Instituto de Salud Carlos III (ISCIII).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Modulation of the endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on executive functions in humans

  • Fagundo, Ana B.
  • Torre Fornell, Rafael de la
  • Jiménez Murcia, Susana
  • Agüera, Zaida
  • Pastor, Antonio
  • Casanueva, Felipe F.
  • Granero, Roser
  • Baños, Rosa M.
  • Botella, Cristina
  • de Pino Gutiárrez, Amparo
  • Fernández Real, Jose M.
  • Fernández García, José C.
  • Frühbeck, Gema
  • Gómez Ambrosi, Javier
  • Menchón, José M.
  • Moragrega, Inés
  • Rodríguez, Roser
  • Tárrega, Salomé
  • Tinahones Madueño, Francisco José
  • Fernández Aranda, Fernando
Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognitive flexibility) in healthy subjects. One hundred and fifty seven subjects were included and assessed with the Wisconsin Card Sorting Test; Stroop Color and Word Test; and Iowa Gambling Task. All participants were female, aged between 18 and 60 years and spoke Spanish as their first language. Results showed a negative correlation between 2-AG and cognitive flexibility performance (r = −.37; p<.05). A positive correlation was found between AEA concentrations and both cognitive flexibility (r = .59; p<.05) and decision making performance (r = .23; P<.05). There was no significant correlation between either 2-AG (r = −.17) or AEA (r = −.08) concentrations and inhibition response. These results show, in humans, a relevant modulation of the endocannabinoid system on prefrontal-dependent cognitive functioning. The present study might have significant implications for the underlying executive alterations described in some psychiatric disorders currently associated with endocannabinoids deregulation (namely drug abuse/dependence, depression, obesity and eating disorders). Understanding the neurobiology of their dysexecutive profile might certainly contribute to the development of new treatments and pharmacological approaches., Financial support was received from Fondo de Investigación Sanitaria - FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718). Ministerio de Ciencia e Innovación Subprograma Juan de la Cierva (JCI-2011-09248). CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCII
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Modulation of Higher-Order Olfaction Components on Executive Functions in Humans

  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Giner Bartolomé, Cristina|||0000-0003-3129-5326
  • Islam, Mohammed Anisul|||0000-0001-7240-2971
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Pastor, Antoni|||0000-0003-3692-0696
  • Casanueva, Felipe F.|||0000-0002-9052-8161
  • Crujeiras, Ana B.|||0000-0003-4392-0301
  • Granero, Roser|||0000-0001-6308-3198
  • Baños, Rosa|||0000-0003-0626-7665
  • Botella, Cristina|||0000-0001-8783-6959
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Gómez-Ambrosi, Javier|||0000-0001-5601-1604
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
The prefrontal (PFC) and orbitofrontal cortex (OFC) appear to be associated with both executive functions and olfaction. However, there is little data relating olfactory processing and executive functions in humans. The present study aimed at exploring the role of olfaction on executive functioning, making a distinction between primary and more cognitive aspects of olfaction. Three executive tasks of similar difficulty were used. One was used to assess hot executive functions (Iowa Gambling Task-IGT), and two as a measure of cold executive functioning (Stroop Colour and Word Test-SCWT and Wisconsin Card Sorting Test-WCST). Sixty two healthy participants were included: 31 with normosmia and 31 with hyposmia. Olfactory abilities were assessed using the ''Sniffin' Sticks'' test and the olfactory threshold, odour discrimination and odour identification measures were obtained. All participants were female, aged between 18 and 60. Results showed that participants with hyposmia displayed worse performance in decision making (IGT; Cohen's- d = 0.91) and cognitive flexibility (WCST; Cohen's- d between 0.54 and 0.68) compared to those with normosmia. Multiple regression adjusted by the covariates participants' age and education level showed a positive association between odour identification and the cognitive inhibition response (SCWT-interference; Beta = 0.29; p =.034). The odour discrimination capacity was not a predictor of the cognitive executive performance. Our results suggest that both hot and cold executive functions seem to be associated with higher-order olfactory functioning in humans. These results robustly support the hypothesis that olfaction and executive measures have a common neural substrate in PFC and OFC, and suggest that olfaction might be a reliable cognitive marker in psychiatric and neurologic disorders.